π΅οΈ Galectin Therapeutics Inc ($GALT)
SEC insider & ownership activity, last 12 months Β· CIK 1133416 Β· every row links its SEC filing
Over the last 12 months insiders sold $6.4M against $26K of open-market buying. 10X Fund, L.P. sold $1.7M (AprβDec). 2 planned sales are pending, the largest $39K (Harold Shlevin). No red-flag 8-Ks in the window.
π¨ 2 signals active β
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $26K (4 lots) Β· 5 sellers, $6.4M (71 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| 10X Fund, L.P. | 0 | β | 8 | $1.7M | Dec 16, 2025 |
| Harold H. Shlevin | 0 | β | 14 | $1.6M | Jun 29, 2026 |
| Jamil Khurram | 0 | β | 17 | $1.4M | Jul 14, 2026 |
| Jack W. Callicutt | 0 | β | 21 | $1.0M | Jan 6, 2026 |
| Lewis Joel | 0 | β | 11 | $710K | Jan 6, 2026 |
| Kevin D. Freeman | 1 | $20K | 0 | β | Dec 23, 2025 |
| Eldred Kary | 3 | $6K | 0 | β | Feb 6, 2026 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Harold Shlevin | $112K | Jun 29, 2026 | filing β |
| Jamil Khurram | $341K | Jun 26, 2026 | filing β |
| Harold Shlevin | $39K | Jun 26, 2026 | filing β |
| Jamil Khurram | $26K | Jun 23, 2026 | filing β |
| Jack W. Callicutt | $252K | Jan 2, 2026 | filing β |
| Lewis Joel | $353K | Jan 2, 2026 | filing β |
| Jamil Khurram | $252K | Jan 2, 2026 | filing β |
| Harold H. Shlevin | $1.8M | Jan 2, 2026 | filing β |
| Jamil Khurram | $33K | Dec 31, 2025 | filing β |
| Jamil Khurram | $151K | Dec 17, 2025 | filing β |
| Lewis Joel | $282K | Dec 17, 2025 | filing β |
| Harold Shlevin | $172K | Dec 17, 2025 | filing β |
| Harold Shlevin | $53K | Dec 15, 2025 | filing β |
| Harold Shlevin | $123K | Dec 12, 2025 | filing β |
| Harold Shlevin | $104K | Dec 9, 2025 | filing β |
| Harold Shlevin | $957K | Dec 8, 2025 | filing β |
| Jamil Khurram | $660K | Nov 13, 2025 | filing β |
| Lewis Joel | $345K | Sep 12, 2025 | filing β |
| Jack W. Callicutt | $909K | Sep 12, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 23, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing β |
| Earnings (2.02) | May 15, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing β |
| Earnings (2.02) | Mar 31, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing β |
| Officer/director changes (5.02) | Mar 12, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing β |
| Officer/director changes (5.02) | Jan 16, 2026 | filing β |
| Officer/director changes (5.02) | Jan 10, 2026 | filing β |
| Material agreement (1.01) | Dec 19, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Dec 19, 2025 | filing β |
| Shareholder vote (5.07) | Dec 3, 2025 | filing β |
| Reg FD disclosure (7.01) | Dec 3, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Dec 3, 2025 | filing β |
| Earnings (2.02) | Nov 14, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing β |
| Reg FD disclosure (7.01) | Nov 10, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing β |
| Reg FD disclosure (7.01) | Sep 8, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Sep 8, 2025 | filing β |
| Earnings (2.02) | Aug 14, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 14, 2025 | filing β |